Max Healthcare Institute Limited has increased its shareholding in its subsidiary, Kalinga Hospital Ltd. (KHL), to approximately 66.15% following a rights issue. The company received communication on September 7, 2026, confirming the allotment of 50,21,212 equity shares. This move solidifies KHL’s status as a subsidiary and reflects Max Healthcare’s commitment to its growth.
Max Healthcare Increases Stake in Kalinga Hospital
Max Healthcare Institute Limited announced today, September 7, 2026, that it has successfully increased its shareholding in its subsidiary, Kalinga Hospital Ltd. (KHL). This significant development follows the company’s earlier intimation on September 3, 2026, regarding the infusion of approximately ₹87.87 Crore into KHL.
Rights Issue and Shareholding Update
The infusion was executed through a rights issue, wherein Max Healthcare subscribed to new equity shares of KHL. On September 7, 2026, at 5.13 pm IST, the company received official confirmation from KHL regarding the allotment of 50,21,212 equity shares to Max Healthcare. This allotment has resulted in an increase in Max Healthcare’s shareholding in KHL from approximately 58.28% to 66.15%.
Subsidiary Status Maintained
Following this increased stake, Kalinga Hospital Ltd. continues to remain a subsidiary of Max Healthcare Institute Limited. The company has also stated that this disclosure will be hosted on its official website, www.maxhealthcare.in.
Source: BSE
